MiNK Therapeutics, Inc.

NasdaqCM:INKT Stock Report

Market Cap: US$59.9m

MiNK Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:INKT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Jun 26SellUS$19,141Barbara RyanIndividual1,500US$12.80
10 Mar 26SellUS$20,017Barbara RyanIndividual1,300US$15.57
09 Mar 26SellUS$2,035Barbara RyanIndividual200US$10.17
02 Mar 26SellUS$5,426Barbara RyanIndividual500US$10.86

Insider Trading Volume

Insider Buying: INKT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of INKT?
Owner TypeNumber of SharesOwnership Percentage
Institutions125,8322.53%
Individual Insiders852,41517.1%
General Public1,826,36636.7%
Public Companies2,177,28643.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 25%.

Top Shareholders

Top 25 shareholders own 63.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
43.7%
Agenus Inc.
2,177,286US$26.2m0%no data
9.31%
Yekaterina Chudnovsky
464,000US$5.6m0%no data
3.47%
Garo Armen
172,800US$2.1m0%no data
1.19%
Vanguard Capital Management, LLC
59,364US$713.6k0%no data
1.16%
Jennifer Buell
57,942US$696.5k58.8%no data
1.04%
Brian Corvese
51,693US$621.4k6.71%no data
0.99%
Ulf Wiinberg
49,349US$593.2k5.44%no data
0.44%
Barbara Ryan
21,969US$264.1k26.7%no data
0.43%
Peter Behner
21,606US$259.7k15.9%no data
0.35%
Geode Capital Management, LLC
17,345US$208.5k21.7%no data
0.33%
Longbow Finance SA
16,667US$200.3k0%0.03%
0.31%
UBS Asset Management AG
15,202US$182.7k59.2%no data
0.17%
Vanguard Fiduciary Trust Company
8,287US$99.6k0%no data
0.12%
BlackRock, Inc.
6,203US$74.6k0%no data
0.12%
Christine Klaskin
5,789US$69.6k0%no data
0.093%
Marcus van Dijk
4,638US$55.8k0%no data
0.048%
John Holcomb
2,367US$28.5k0%no data
0.04%
Steward Partners Investment Advisory, LLC
2,000US$24.0k0%no data
0.0045%
Melissa Orilall
222US$2.7k0%no data
0.004%
Annis Gardner Whiting Capital Advisors LLC
200US$2.4k0%no data
0.0031%
Tower Research Capital Europe Limited
156US$1.9k-47.1%no data
0.0024%
Covestor Ltd
119US$1.4k-9.16%no data
0.0021%
Morgan Stanley
104US$1.3k0%no data
0.0018%
Citigroup Inc.
91US$1.1k-73%no data
0.0008%
Austin Charette
40US$479.10%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/12 11:28
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MiNK Therapeutics, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mayank MamtaniB. Riley Securities, Inc.
Kalpit PatelB. Riley Securities, Inc.
Maneka MirchandaneyEvercore ISI